UniSa - IRIS Institutional Research Information System

PERSICO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.455
AS - Asia 2.661
EU - Europa 2.617
SA - Sud America 385
AF - Africa 35
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.174
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.366
SG - Singapore 956
CN - Cina 827
UA - Ucraina 631
IT - Italia 558
RU - Federazione Russa 414
BR - Brasile 353
DE - Germania 309
IE - Irlanda 237
VN - Vietnam 224
KR - Corea 212
FI - Finlandia 170
TR - Turchia 152
HK - Hong Kong 146
SE - Svezia 103
CA - Canada 73
GB - Regno Unito 51
IN - India 31
AT - Austria 28
FR - Francia 26
DK - Danimarca 25
JP - Giappone 25
NL - Olanda 24
BD - Bangladesh 17
ZA - Sudafrica 13
AU - Australia 11
MX - Messico 11
TW - Taiwan 11
ES - Italia 10
EC - Ecuador 9
AR - Argentina 7
CO - Colombia 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
EU - Europa 6
PK - Pakistan 6
IQ - Iraq 5
PL - Polonia 5
UZ - Uzbekistan 5
VE - Venezuela 5
AZ - Azerbaigian 4
MA - Marocco 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CH - Svizzera 3
EG - Egitto 3
GR - Grecia 3
IR - Iran 3
LT - Lituania 3
MY - Malesia 3
RO - Romania 3
TH - Thailandia 3
HN - Honduras 2
ID - Indonesia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
UG - Uganda 1
Totale 13.174
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.681
Chandler 838
Jacksonville 819
Princeton 723
Woodbridge 520
Wilmington 366
Houston 295
Singapore 271
Dublin 229
Ashburn 222
Dong Ket 217
Beijing 209
Andover 164
Nanjing 146
Izmir 142
Pellezzano 128
Hong Kong 122
Boardman 120
Moscow 94
Munich 72
Salerno 64
Hebei 55
Shenyang 54
Naples 50
The Dalles 47
Ottawa 46
Fairfield 45
Changsha 44
Los Angeles 42
Nanchang 42
Norwalk 42
Columbus 41
Dallas 39
Jiaxing 39
Düsseldorf 33
Redwood City 33
Tianjin 29
Jinan 28
São Paulo 26
Turku 26
Washington 26
Mestre 25
Nuremberg 25
Falls Church 20
Dearborn 19
Guangzhou 19
San Diego 17
Seattle 17
Belo Horizonte 16
Council Bluffs 16
New York 16
Santa Clara 15
Tokyo 15
London 14
Helsinki 13
Nürnberg 13
Rio de Janeiro 13
Vienna 13
Brooklyn 12
Cambridge 12
Lappeenranta 12
Pune 12
Zhengzhou 12
Copenhagen 11
Amsterdam 10
Fisciano 10
Jinju 10
Milan 10
San Mango Piemonte 10
Boston 9
Haikou 9
Johannesburg 9
Maletto 9
Montreal 9
Rome 9
Brasília 8
Phoenix 8
San Francisco 8
San Jose 8
Pontecagnano 7
San Giorgio A Cremano 7
Shanghai 7
Dhaka 6
Ningbo 6
Saint Petersburg 6
Salvador 6
Shenzhen 6
Bologna 5
Brno 5
Caxias do Sul 5
Chicago 5
Curitiba 5
Edmonton 5
Frankfurt am Main 5
Ha Kwai Chung 5
Hangzhou 5
Melbourne 5
Napoli 5
Porto Alegre 5
Redmond 5
Totale 8.838
Salva come PNG Salva come JPEG
Nome #
Prospective validation of the CLIP score: a new prognostic system for patient with cirrhosis and hepatocellular carcinoma 282
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 138
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 126
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 125
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. 120
HIGH PREVALENCE OF HEPATITIS C (HCV) INFECTION AND FAVORABLE PROGNOSIS IN PRIMARY HEPATIC LYMPHOMA (PHL) 119
Coeliac disease and C virus-related chronic hepatitis: a non association 116
"Non alcoholic fatty liver disease and eNOS dysfunction in humans" 113
Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment 112
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 110
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 109
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. 107
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 105
Alcoholic Liver Disease and Hepatitis C Chronic Infection 103
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 99
Ultrasound-guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: results in 15 patients. 96
Antiviral therapy: Why does it fail in HCV-related chronic hepatitis? 96
Age-associated decline of hepatic handling of cholephilic anions in humans is reverted by S-adenosylmethionine (SAMe). 95
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma 94
A controlled trial on treatment of patients with HCV infection and abnormal liver function tests with or without liver biopsy 94
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report. 94
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. 94
Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients 93
[629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP) 93
Risk factors for hospital readmission of elderly patients. 93
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 91
[Diabetic neuropathies. IV. Autonomous neuropathy. Peripheral sympathetic innervation and the cardiovascular system]. 90
Electrophysiological evidence for Na+-coupled bicarbonate transport in cultured rat hepatocytes 90
154 LOW RATE OF ONE-YEAR MORTALITY IN PATIENTS WITH STAGE 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (A.I.S.F.)-EPASCO PROSPECTIVE MULTICENTRE STUDY 88
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 88
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 88
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. 87
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition? 87
A 15-Yr Prospective Histological Follow-Up Study in Patients With Persistently Normal Aminotransferase Levels (PNAL) Carrying HCV Infection. 85
Pharmacotherapy of alcoholic liver disease in clinical practice 84
507 The role of HBV occult infection in patients with non-hodgkin lymphoma: Prevalence and treatment options with nucleotide analogues 84
Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563] (DOI:10.1016/j.jhep.2008.06.025) 84
Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients. 83
Epidemiology and Natural History of Alcoholic Liver Disease 83
A randomised controlled trial on pegylated interferon alfa-2a (40kd)(Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV 82
478 Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study 81
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. 80
The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: Role of endothelial dysfunction 80
Impact of telaprevir in HCV patients with cirrhosis and RVR: Real-life data from boceprevir or telaprevir based “triple therapy” experience in southern Italy 80
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 79
Na+-H+ exchange activity in rat hepatocytes: Role in regulation of intracellular pH 78
Steatosis as a co-factor in chronic liver diseases 78
FN 44 HEPATIC RETINOL BINDING PROTEIN 4 (RBP-4) LEVELS ARE SIGNIFICANTLY RELATED TO THE STEATOHEPATITIS GRADE (COMPROMISSION) BUT NOT WITH HCV INFECTION 78
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study. 78
Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: Results of a prospective multicentric study 78
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C 77
A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis 76
442 TNF-alpha and IL-10 genetic polymorphisms influence the natural history and the response to antiviral therapy in HCV related chronic hepatitis 76
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease 76
Abnormal hepatic uptake of low doses of sulfobromophthalein in Gilbert's syndrome: the role of reduced affinity of the plasma membrane carrier of organic anions. 76
Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. 75
Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. 74
Chronic liver disease and lymphoproliferative disorders in HCV-positive patients: a working hypothesis. 74
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. 74
Non Alcoholic Fatty Liver: Epidemiology and Natural History 74
Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. 73
Alanine aminotransferase measurements and histological disease in hepatitis C. 73
Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. 72
93 HCV genotype 2 and 3 can be cured by PEG-IFN-alfa-2B and RBV for 12 wks: A randomized controlled study 72
The importance of HCV on burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases 72
Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans. 71
Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. 71
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma. 71
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. 70
Clinical management of HCV carriers with normal aminotransferase levels. 70
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 70
Long-term liver histology improvement in patients with chronic hepatitis B and sustained response to interferon 70
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 70
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis. 69
The clinical significance of occult HBV infection in acute delta virus hepatitis in a case of immunosuppressive therapy for non-Hodgkin lymphomas. 69
Erratum to: HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas 69
Dissociation between vascular and metabolic effects of nicotinic acid in Gilbert's syndrome. 68
HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas 68
Dose dependence of nicotinic acid-induced hyperbilirubinemia and its dissociation from hemolysis in Gilbert's syndrome. 67
Improvement of the nicotinic acid test in the diagnosis of Gilbert's syndrome by pretreatment with indomethacin. 67
Interference of diet on liver histology and on the response to interferon therapy in patients with HCV-related chronic liver disease 67
Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study. 67
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial. 67
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 67
Prevalence and incidence of cryoglobulins in hepatitis C virus-related chronic hepatitis patients: a prospective study. 66
Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma. 66
[Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach]. 66
Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study 66
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 66
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 66
Evaluation of allelic frequency and genetic risk score of non-alcoholic fatty liver disease in a population of Southern Italy 66
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 65
Adiponectin in hepatology 65
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system]. 64
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 64
Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis. 64
Sex steroid modulation of the hepatic uptake of organic anions in rat. 63
HCV infection and hepatocellular carcinoma in cirrhotics: what is the linkage? 63
P. 253 Rapid virological response in genotype 1b patients treated with peginterferon plus ribavirin: evidence for a significant sustained virological response (SVR) after 24 weeks of therapy in peg-interferon-alpha-2a treated patients 63
The diagnostic conundrum in non-alcoholic fatty liver disease 63
Totale 8.368
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.291 52 126 139 20 149 52 160 13 135 12 180 253
2021/20221.248 6 3 8 6 26 24 34 58 193 169 156 565
2022/20232.009 207 118 63 237 291 430 12 185 301 5 108 52
2023/2024890 82 120 69 32 71 140 32 44 8 34 51 207
2024/20252.756 73 46 56 118 152 290 434 323 486 170 291 317
2025/2026180 180 0 0 0 0 0 0 0 0 0 0 0
Totale 13.543